Clin2
NCT06386094Possibly a fitRecruiting

Fatty Liver Disease and Heart Function Study

NAFLDCardiac DiseaseFatty LiverMASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease

Part of Digestive system, Heart & circulation clinical trials.

This study checks how fatty liver disease (a condition where fat builds up in the liver) affects the heart. If you have this liver condition and are between 18 and 65, you may help doctors understand the link between liver health and heart function.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
150 people
Ages
18 years to 65 years
Study type
Observational

Who can take part

  • You are between 18 and 65 years old
  • You have been diagnosed with fatty liver disease (related to metabolism) – this can be found by a liver biopsy, blood tests, or imaging like ultrasound or a special scan (VCTE)
  • You do not have serious kidney disease, uncontrolled high blood pressure, or heart conditions like valve disease, a pacemaker, or rhythm problems
  • You do not have thyroid problems (overactive or underactive)
  • You do not have severe anemia (low red blood cells) or advanced liver problems like liver cancer or a TIPS shunt

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04036357Recruiting
Study of liver fat disease with heart and metabolism problems

This study looks at people with fatty liver disease and common health issues like obesity, diabetes, high blood pressure, or abnormal cholesterol. It may help researchers understand how liver fat and heart/metabolism problems relate and how they affect health over time.

Rome
NCT06826807Enrolling by invitation
Lifestyle change study for fatty liver disease

This study tests whether adding a liver stiffness measurement to a lifestyle program helps people with MASLD (a type of fatty liver disease) improve their liver health. It is designed for people who have fatty liver and at least one sign of metabolic syndrome, like high blood pressure or diabetes.

Bangkoknoi, Bangkok
NCT04873258Recruiting
Test a non-invasive tool to screen for fat-related liver disease

This study looks at a new non-invasive screening method to predict metabolic dysfunction–associated steatotic liver disease (MASLD), a condition where fat builds up in the liver. The goal is to help identify people who may be at risk without needing invasive tests.

London, London
NCT07775638Not yet recruiting
Liver fibrosis screening for at-risk adults

This study tests a way to find liver scarring (fibrosis) early in people who have risk factors like being overweight, having type 2 diabetes, or drinking alcohol heavily. Early detection may help prevent serious liver damage.

Stavanger
NCT06456970Not yet recruiting
Fatty Liver and Heart Attack Risk Study

This study is looking at how common a certain type of fatty liver disease is in people who have had a heart attack or unstable angina. If you've recently had a heart event and a coronary angiogram, the study will check your liver health to see if there is a link.

NCT04371042Recruiting
Study of liver disease and genes in people with fatty liver

This study collects information about metabolic and unexplained (cryptogenic) liver disease and looks at “omics” tests, which are lab tests that measure patterns in blood or tissue to learn what drives the disease. It may help researchers better understand fatty liver and related serious complications, like liver scarring and liver cancer.

Roma, Rome/lazio/italy

Hear when a new NAFLD trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.